GlassScriptPhysician profile
Laureb Brunner
NPI 1013583970
$6,568.12
in general payments reported to CMS, 2019-2025
40 companies · $1,616 in 2025
The $1,616 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,270 · 2023: $1,876 · 2024: $1,806 · 2025: $1,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,279 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,278.83 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $804.34 | 2022-2025 | Mounjaro, Zepbound, Emgality |
| Astrazeneca Pharmaceuticals LP | $751.48 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $601.30 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $577.24 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $482.95 | 2022-2025 | Rexulti, Nuedexta |
| Pfizer INC. | $367.61 | 2023-2025 | |
| Amgen INC. | $293.31 | 2023-2025 | Repatha, Otezla, Repatha |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $242.42 | 2022-2025 | Caplyta |
| Lundbeck LLC | $221.22 | 2022-2025 | Rexulti, Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $216.49 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $204.58 | 2022-2024 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $179.18 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $154.34 | 2023-2025 | |
| Glaxosmithkline, LLC. | $129.52 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Sanofi-Aventis U.S. LLC | $125.71 | 2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $115.42 | 2023-2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $112.40 | 2024-2025 | Auvelity, Symbravo |
| Idorsia Pharmaceuticals US INC | $111.36 | 2023-2024 | Tryvio, Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.86 | 2023-2025 | Tradjenta, Jardiance |
| Phathom Pharmaceuticals, INC. | $74.31 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $69.53 | 2023-2025 | Gardasil 9, Capvaxive, Gardasil |
| Esperion Therapeutics, INC. | $63.30 | 2023-2025 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.03 | 2024-2025 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $59.62 | 2025 | Ajovy |
| Inspire Medical Systems, INC. | $52.59 | 2023-2025 | Inspire |
| Dexcom, INC. | $39.00 | 2024 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $36.93 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Tris Pharma INC | $34.03 | 2023-2024 | Dyanavel Xr |
| Corium, LLC | $33.83 | 2023 | Azstarys |
| Vanda Pharmaceuticals INC. | $33.71 | 2024 | Fanapt |
| Amarin Pharma, INC. | $31.97 | 2022 | |
| Daiichi Sankyo INC. | $24.27 | 2024 | Injectafer |
| Avanir Pharmaceuticals, INC. | $23.78 | 2022 | |
| Ucb, INC. | $23.64 | 2025 | Rystiggo |
| Astellas Pharma US INC | $22.24 | 2025 | Veozah |
| Abbott Laboratories | $20.07 | 2025 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $19.19 | 2022 | |
| Philips North America LLC | $18.13 | 2024 | (Ck6) Holter |
| Paratek Pharmaceuticals, INC. | $16.68 | 2023 | Nuzyra |
| Amneal Pharmaceuticals LLC | $15.54 | 2024 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laureb Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.